Cargando…
Ligand-mediated delivery of RNAi-based therapeutics for the treatment of oncological diseases
RNA interference (RNAi)-based therapeutics (miRNAs, siRNAs) have great potential for treating various human diseases through their ability to downregulate proteins associated with disease progression. However, the development of RNAi-based therapeutics is limited by lack of safe and specific deliver...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291076/ https://www.ncbi.nlm.nih.gov/pubmed/34316717 http://dx.doi.org/10.1093/narcan/zcab030 |